Fractyl Health, Inc. (GUTS)
0.9809
+0.09
(+10.21%)
USD |
NASDAQ |
Oct 29, 16:00
0.96
-0.02
(-2.13%)
After-Hours: 20:00
Fractyl Health Enterprise Value : 25.36M for Oct. 28, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 28, 2026 | 25.36M |
| October 27, 2026 | 25.23M |
| October 26, 2026 | 27.74M |
| October 23, 2026 | 27.87M |
| October 22, 2026 | 28.54M |
| October 21, 2026 | 28.80M |
| October 20, 2026 | 31.18M |
| October 19, 2026 | 31.84M |
| October 16, 2026 | 34.09M |
| October 15, 2026 | 68.59M |
| October 14, 2026 | 67.54M |
| October 13, 2026 | 66.81M |
| October 12, 2026 | 71.90M |
| October 09, 2026 | 72.03M |
| October 08, 2026 | 69.52M |
| October 07, 2026 | 73.35M |
| October 06, 2026 | 74.01M |
| October 05, 2026 | 73.88M |
| October 02, 2026 | 78.10M |
| October 01, 2026 | 85.00M |
| September 30, 2026 | 99.96M |
| September 29, 2026 | 96.09M |
| September 28, 2026 | 88.32M |
| September 25, 2026 | 90.64M |
| September 24, 2026 | 88.15M |
| Date | Value |
|---|---|
| September 23, 2026 | 90.64M |
| September 22, 2026 | 101.33M |
| September 21, 2026 | 104.30M |
| September 18, 2026 | 108.79M |
| September 17, 2026 | 107.33M |
| September 16, 2026 | 102.84M |
| September 15, 2026 | 103.23M |
| September 14, 2026 | 110.63M |
| September 11, 2026 | 115.13M |
| September 10, 2026 | 115.62M |
| September 09, 2026 | 115.13M |
| September 08, 2026 | 122.30M |
| September 04, 2026 | 124.11M |
| September 03, 2026 | 122.64M |
| September 02, 2026 | 125.71M |
| September 01, 2026 | 125.94M |
| August 31, 2026 | 126.36M |
| August 28, 2026 | 118.15M |
| August 27, 2026 | 131.28M |
| August 26, 2026 | 130.54M |
| August 25, 2026 | 137.95M |
| August 24, 2026 | 132.58M |
| August 21, 2026 | 137.34M |
| August 20, 2026 | 122.29M |
| August 19, 2026 | 122.43M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Co-Diagnostics, Inc. | 0.3026M |
| Spectral AI, Inc. | 52.48M |
| Vaxcyte, Inc. | 7.527B |
| Moderna, Inc. | 81.60B |
| Arrowhead Pharmaceuticals, Inc. | 8.272B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -25.54M |
| Total Expenses (Quarterly) | 25.54M |
| EPS Diluted (Quarterly) | -1.932 |
| Earnings Yield | -1.34K% |
| Normalized Earnings Yield | -1036.25 |